175 related articles for article (PubMed ID: 38455061)
1. Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers.
Reis B; Attig J; Dziadek S; Graefe N; Heller A; Rieder N; Gomes B
Front Immunol; 2024; 15():1285049. PubMed ID: 38455061
[TBL] [Abstract][Full Text] [Related]
2. γδ T cells are effectors of immunotherapy in cancers with HLA class I defects.
de Vries NL; van de Haar J; Veninga V; Chalabi M; Ijsselsteijn ME; van der Ploeg M; van den Bulk J; Ruano D; van den Berg JG; Haanen JB; Zeverijn LJ; Geurts BS; de Wit GF; Battaglia TW; Gelderblom H; Verheul HMW; Schumacher TN; Wessels LFA; Koning F; de Miranda NFCC; Voest EE
Nature; 2023 Jan; 613(7945):743-750. PubMed ID: 36631610
[TBL] [Abstract][Full Text] [Related]
3. Characterization of MHC Class I and β-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic Trials.
Haworth KB; Arnold MA; Pierson CR; Leddon JL; Kurmashev DK; Swain HM; Hutzen BJ; Roberts RD; Cripe TP
Pediatr Blood Cancer; 2016 Apr; 63(4):618-26. PubMed ID: 26575538
[TBL] [Abstract][Full Text] [Related]
4. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
5. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
[TBL] [Abstract][Full Text] [Related]
6. Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes.
Castro A; Ozturk K; Pyke RM; Xian S; Zanetti M; Carter H
BMC Med Genomics; 2019 Jul; 12(Suppl 6):107. PubMed ID: 31345234
[TBL] [Abstract][Full Text] [Related]
7. Expression of human leukocyte antigen class I and β2-microglobulin in colorectal cancer and its prognostic impact.
Na HY; Park Y; Nam SK; Lee KS; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
Cancer Sci; 2021 Jan; 112(1):91-100. PubMed ID: 33159376
[TBL] [Abstract][Full Text] [Related]
8. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.
Garrido MA; Rodriguez T; Zinchenko S; Maleno I; Ruiz-Cabello F; Concha Á; Olea N; Garrido F; Aptsiauri N
Immunogenetics; 2018 Nov; 70(10):647-659. PubMed ID: 30145665
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition.
Del Campo AB; Carretero J; Muñoz JA; Zinchenko S; Ruiz-Cabello F; González-Aseguinolaza G; Garrido F; Aptsiauri N
Cancer Gene Ther; 2014 Aug; 21(8):317-32. PubMed ID: 24971583
[TBL] [Abstract][Full Text] [Related]
10. Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.
Baba T; Hanagiri T; Ichiki Y; Kuroda K; Shigematsu Y; Mizukami M; Sugaya M; Takenoyama M; Sugio K; Yasumoto K
Cancer Sci; 2007 Nov; 98(11):1795-802. PubMed ID: 17725806
[TBL] [Abstract][Full Text] [Related]
11. Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.
Restifo NP; Marincola FM; Kawakami Y; Taubenberger J; Yannelli JR; Rosenberg SA
J Natl Cancer Inst; 1996 Jan; 88(2):100-8. PubMed ID: 8537970
[TBL] [Abstract][Full Text] [Related]
12. Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies
Pereira C; Gimenez-Xavier P; Pros E; Pajares MJ; Moro M; Gomez A; Navarro A; Condom E; Moran S; Gomez-Lopez G; Graña O; Rubio-Camarillo M; Martinez-Martí A; Yokota J; Carretero J; Galbis JM; Nadal E; Pisano D; Sozzi G; Felip E; Montuenga LM; Roz L; Villanueva A; Sanchez-Cespedes M
Clin Cancer Res; 2017 Jun; 23(12):3203-3213. PubMed ID: 28302866
[No Abstract] [Full Text] [Related]
13. Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.
Paschen A; Méndez RM; Jimenez P; Sucker A; Ruiz-Cabello F; Song M; Garrido F; Schadendorf D
Int J Cancer; 2003 Mar; 103(6):759-67. PubMed ID: 12516095
[TBL] [Abstract][Full Text] [Related]
14. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.
del Campo AB; Kyte JA; Carretero J; Zinchencko S; Méndez R; González-Aseguinolaza G; Ruiz-Cabello F; Aamdal S; Gaudernack G; Garrido F; Aptsiauri N
Int J Cancer; 2014 Jan; 134(1):102-13. PubMed ID: 23784959
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide association study identified the human leukocyte antigen region as a novel locus for plasma beta-2 microglobulin.
Tin A; Astor BC; Boerwinkle E; Hoogeveen RC; Coresh J; Kao WH
Hum Genet; 2013 Jun; 132(6):619-27. PubMed ID: 23417110
[TBL] [Abstract][Full Text] [Related]
16. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
[TBL] [Abstract][Full Text] [Related]
17. Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy.
Wang H; Liu B; Wei J
Cancer Lett; 2021 Oct; 517():96-104. PubMed ID: 34129878
[TBL] [Abstract][Full Text] [Related]
18. Lynch syndrome-associated epithelial ovarian cancer and its immunological profile.
Rasmussen M; Lim K; Rambech E; Andersen MH; Svane IM; Andersen O; Jensen LH; Nilbert M; Therkildsen C
Gynecol Oncol; 2021 Sep; 162(3):686-693. PubMed ID: 34275654
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of a mouse tumor cell line with irreversible downregulation of MHC class I molecules.
Lhotakova K; Grzelak A; Polakova I; Vackova J; Smahel M
Oncol Rep; 2019 Dec; 42(6):2826-2835. PubMed ID: 31638243
[TBL] [Abstract][Full Text] [Related]
20. Confirmation that somatic mutations of beta-2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial.
Barrow P; Richman SD; Wallace AJ; Handley K; Hutchins GGA; Kerr D; Magill L; Evans DG; Gray R; Quirke P; Hill J
Histopathology; 2019 Aug; 75(2):236-246. PubMed ID: 31062389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
